Pegozafermin
In human trialsMeasured in people, not heightBy injectionProtein or enzyme
A copy of the fasting hormone FGF21, in late trials for liver disease in adults.
An FGF21 analogue, in phase 3 for non-cirrhotic MASH and for compensated cirrhosis due to MASH, both in adults aged 18 to 80. Not approved.
Risks. In the adult trials its common side effects were nausea and diarrhoea. It has only been given to adults.
On this page
- At the growth plate, members only
- Risks and side effects, members only
The rest of this page is for members
What has been measured, in whom, with every source, and what it does to the rest of you. And every article in the library.
Join for $11.99Lifetime · 3 of 10 founding spots left
Tax is added at checkout (VAT/GST where it applies).
Renews every month at the current price plus tax until you cancel. Cancel from your account before the next monthly charge to stop it.
Card purchases are sold and charged by Link (Stripe) under Link's terms and refund policy.
Already a member? Sign in
Educational content, not medical advice. Nothing here is a recommendation to take or stop taking anything — talk to a doctor about your own situation.